• Home
  • 2nd Opinions
  • B-School Cases
  • CMP™ Online
  • Coaching
  • Invite Marcinko
  • Sponsor
  • Photo Sharing
  • Press
  • “MEDICAL EXECUTIVE-POST”
  • NEWSLETTER REQUEST
  • Understanding Knowledge Based Ranking Services
  • Why Post Your e-Content or Print Publish with Us?
  • Job Posts Classified Ads
  • Why Subscribe to the ME-P?
  • Channel Partnerships

The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants

Entries RSS | Comments RSS
  • Member Statistics

    • 926,289 Colleagues-to-Date [Sponsored by a generous R&D grant from iMBA, Inc.]
  • ME-P Information & Content Channels

  • Ann Miller RN MHA [Managing Editor]

    ME-P SYNDICATIONS:
    WSJ.com,
    CNN.com,
    Forbes.com,
    WashingtonPost.com,
    BusinessWeek.com,
    USNews.com, Reuters.com,
    TimeWarnerCable.com,
    e-How.com,
    News Alloy.com,
    and Congress.org

    Comprehensive Financial Planning Strategies for Doctors and Advisors: Best Practices from Leading Consultants and Certified Medical Planners(TM)

    Product Details

    Product Details

    Product Details

  • CERTIFIED MEDICAL PLANNER® program

    New "Self-Directed" Study Option SinceJanuary 1, 2020
  • Most Recent ME-Ps

    • COVID PANDEMIC: Official National Emergency Ending
    • Why and How to Become a Certified Medical Planner™
    • GAS PRICES: Up Again!
    • DAILY UPDATE: Markets Lower – Again!
    • PODCASTS: Corporate Practice of Medicine Laws
    • DAILY UPDATE: From Rage Applying & Quiet Quitting to the Great Employment “Re-Commitment”?
    • HEALTHCARE: Top A.I. Companies to Watch!
    • Advertise on the MEDICAL EXECUTIVE-POST: Reap Benefits in 2023?
    • PODCAST: How Doctors are Really Paid?
    • FAs & CPAs Wanted -BUT- Certified Medical Planners® Needed?
    • PHYSICIAN: COACHING & SECOND OPINIONS
    • Artificial Intelligence Passes U.S. Medical Licensing Exam
    • Invite Dr. Marcinko to Mask-Up and Speak at your Next Seminar, Webcast or Event in 2023?
    • AMERICANS: Cash Savings Rate Up!
    • DAILY UPDATE: IBM and SAP Lay-Offs but Equities Positive
    • PRIVATE EQUITY: Ownership in Physician Practices
    • DAILY UPDATE: Stocks Rise with Economic Data
    • AMAZON: Launches “RxPass” Generic Drug Subscription Program
    • DAILY UPDATE: Markets Morass & Walgreens Boots Alliance
    • PODCAST: Farzad Mostashari MD and “Aledade”Primary Care
    • DAILY UPDATE: Serta-Simmons Bedding and the Directionless Stock Markets
    • PODCAST: Medicare Advantage Plan Over Payments
    • IRS TAX FILING: Joint or Separate for Married Couples?
    • DAILY UPDATE: Stocks Gain But “Spotify” Down
    • PODCAST: Hospital Money Problems 2023
  • PodiatryPrep.org


    BOARD CERTIFICATION EXAM STUDY GUIDES
    Lower Extremity Trauma
    [Click on Image to Enlarge]

  • ME-P Free Advertising Consultation

    The “Medical Executive-Post” is about connecting doctors, health care executives and modern consulting advisors. It’s about free-enterprise, business, practice, policy, personal financial planning and wealth building capitalism. We have an attitude that’s independent, outspoken, intelligent and so Next-Gen; often edgy, usually controversial. And, our consultants “got fly”, just like U. Read it! Write it! Post it! “Medical Executive-Post”. Call or email us for your FREE advertising and sales consultation TODAY [770.448.0769]

    Product Details

    Product Details

    Product Details
  • Medical & Surgical e-Consent Forms

    ePodiatryConsentForms.com
  • iMBA Inc., OFFICES

    Suite #5901 Wilbanks Drive, Norcross, Georgia, 30092 USA [1.770.448.0769]. Our location is real and we are now virtually enabled to assist new long distance clients and out-of-town colleagues.

  • ME-P Publishing

  • SEEKING INDUSTRY INFO PARTNERS?

    If you want the opportunity to work with leading health care industry insiders, innovators and watchers, the “ME-P” may be right for you? We are unbiased and operate at the nexus of theoretical and applied R&D. Collaborate with us and you’ll put your brand in front of a smart & tightly focused demographic; one at the forefront of our emerging healthcare free marketplace of informed and professional “movers and shakers.” Our Ad Rate Card is available upon request [770-448-0769].

  • Reader Comments, Quips, Opinions, News & Updates

    • Dr. Marcinko on THE “MEDICAL EXECUTIVE-POST” MAST HEAD
    • Dr. Marcinko on Google Wants to Replace your Brain
    • Google Wants to Replace your Brain | The Leading Business Education Network and Prime Voice for Doctors, Fiduciary Focused Financial Advisors and Modern Health Industry Consultants on On the Patient Friendly Google Health Initiative
    • Google Wants to Replace your Brain | The Leading Business Education Network and Prime Voice for Doctors, Fiduciary Focused Financial Advisors and Modern Health Industry Consultants on About Google’s Product Graveyard
    • PODCAST: Corporate Practice of Medicine Laws | The Leading Business Education Network and Prime Voice for Doctors, Fiduciary Focused Financial Advisors and Modern Health Industry Consultants on PODCAST: Private Equity Partially Buying Medical Group Practices
    • Anonymous on AMERICANS: Cash Savings Rate Up!
    • CHET on AMERICANS: Cash Savings Rate Up!
    • Anonymous on PRACTICE RISKS IN CORRECTIONAL CARE MEDICINE
    • Anonymous on ChatGPT: A Microsoft Start-Up Venture!
    • PODCAST: How Doctors are Really Paid? | Business Education and Leading Voice for Doctors, Financial Advisors and Health Industry Consultants on How Doctors Get Paid
    • Artificial Intelligence Passes U.S. Medical Licensing Exam | Business Education and Leading Voice for Doctors, Financial Advisors and Health Industry Consultants on Will Future Doctors Need a Medical License?
    • Invite Dr. Marcinko to Mask-Up and Speak at your Next Seminar, Webcast or Event in 2023? | The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants on My Fond Farewell to Tuskegee University
    • AMERICANS: Cash Savings Rate Up! | The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants on New Thoughts on MD Emergency Funds
    • Anonymous on SAVINGS: Rates Plummet!
    • Anonymous on SAVINGS: Rates Plummet!
  • Start-Up Advice for Businesses, DRs and Entrepreneurs

    ImageProxy “Providing Management, Financial and Business Solutions for Modernity”
  • Up-Trending ME-Ps

    • "MEDICAL EXECUTIVE-POST"
    • The Difference Among Pedagogy, Andragogy and Heutagogy
    • THE "MEDICAL EXECUTIVE-POST" MAST HEAD
    • PODCASTS: Corporate Practice of Medicine Laws
    • Recognizing the Differences between Healthcare and Other Industries
    • What is a Stock Market Index IMPLIED OPEN?
    • On Medication Therapy Management (MTM)
    • PODCAST: "UNIVERSAL PRECAUTIONS" EXISTED LONG BEFORE THE CORONA VIRUS
    • PODCAST: Private Equity Partially Buying Medical Group Practices
    • My [Jaguar] Mechanic V. Doctor Story
  • Capitalism and Free Enterprise Advocacy

    Whether you’re a mature CXO, physician or start-up entrepreneur in need of management, financial, HR or business planning information on free markets and competition, the "Medical Executive-Post” is the online place to meet for Capitalism 2.0 collaboration. Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds. THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
  • OIG Fraud Warnings

    Beware of health insurance marketplace scams OIG's Most Wanted Fugitives at oig.hhs.gov

PODCAST: Doctor’s Don’t Disclose Conflicts of Interest

Posted on December 13, 2022 by Dr. Marcinko

C.O.I.

By Eric Bricker MD

***

***

MORE: https://medicalexecutivepost.com/2022/10/05/video-on-doctors-money-and-conflicts-of-interest/

***

COMMENTS APPRECIATED

Thank You

CITE: https://www.r2library.com/Resource/Title/082610254

***

Product Details

ORDER: https://www.amazon.com/Business-Medical-Practice-Transformational-Doctors/dp/0826105750/ref=sr_1_9?ie=UTF8&qid=1448163039&sr=8-9&keywords=david+marcinko

***

Share this:

  • Share on Tumblr
  • WhatsApp
  • More
  • Email
  • Print

Like this:

Like Loading...

Filed under: "Doctors Only", Drugs and Pharma, Ethics, Health Economics, Health Insurance, Professional Liability | Tagged: COI, Conflicts of Interest, Don't Disclose Conflicts of Interest, Drugs, Eric Bricker MD, pharma, pharmaceuticals | Leave a comment »

AbbVie: The Economic Recession Index?

Posted on November 23, 2022 by Dr. Marcinko

The BOTOX Predictor Index?

By Staff Reporters

***

***

It’s looking more than likely that we’ll see a recession in the next year, and Americans are preparing themselves by taking steps like delaying major purchases, allocating more of their income to savings, and staying in jobs they don’t love. Another thing they’re not doing? Getting Botox. And that’s bad news for AbbVie; according to Neal Freyman of Morning Brew.

AbbVie, one of the biggest drug manufacturers in the US, brought Botox into its medical aesthetics portfolio—which also includes the popular dermal filler Juvederm—in 2020, when it bought rival drugmaker Allergan for $63 billion. AbbVie CEO Richard Gonzalez said during the company’s Oct. 28 earnings call that the company expects the aesthetics business to take a hard hit in 2023 as recession fears cause consumers to be more cautious with their spending.

“Based on all the data we’ve been observing, especially in the US, with both the consumer-confidence index and real personal consumption expenditures trending down and continued high inflation, these factors are putting pressure on consumer’s discretionary spending,” Gonzalez said.

AbbVie lowered its 2022 full-year forecast for its aesthetics business by $600 million, down to $5.3 billion. After the earnings call, AbbVie’s stock fell 4.3%. Through the third quarter of 2022, Botox has brought in $1.97 billion for the aesthetics business. The third quarter saw $637 million in cosmetic Botox sales, down from an expected $640 million. Gonzalez said he doesn’t think the hit on sales will last long, though.

***

***

“As consumer confidence improves, we would once again expect the market growth to accelerate. Our aesthetics portfolio experienced a rapid and sustained recovery following the 2008, 2009 recession,” Gonzalez said.

But Botox also faces a new competitor, called Daxxify, which just got FDA approval in September. Made by Revance Therapeutics, the drug may last longer: In clinical trials, Daxxify injections lasted six to nine months, while Botox injections typically last three months.

***

ORDER: https://www.routledge.com/Comprehensive-Financial-Planning-Strategies-for-Doctors-and-Advisors-Best/Marcinko-Hetico/p/book/9781482240283

***

COMMENTS APPRECIATED

Thank You

***

Share this:

  • Share on Tumblr
  • WhatsApp
  • More
  • Email
  • Print

Like this:

Like Loading...

Filed under: "Doctors Only", Alternative Investments, Career Development, Drugs and Pharma, Health Economics, Health Insurance, Healthcare Finance, Investing | Tagged: AbbVie, AbbVie: The Economic Recession?, botex predictor index, economic recession, Morning Brew, pharma | 1 Comment »

PHARMA: Will Americans Finally See Drug Prices Decrease?

Posted on November 4, 2022 by Dr. Marcinko

By Health Capital Consultants, LLC

***

***

According to the White House, “Americans pay two to three times as much as people in other countries for prescription drugs, and one in four Americans who take prescription drugs struggle to afford their medications. Nearly 3 in 10 American adults who take prescription drugs say that they have skipped doses, cut pills in half, or not filled prescriptions due to cost.” In an effort to combat this growing crisis, both the federal government and private companies have taken a number of steps over the past year aiming to lower drug prices. This Health Capital Topics article will review those actions and the potential unintended consequences of these actions.
(Read more…)

COMMENTS APPRECIATED

Thank You

CITE: https://www.r2library.com/Resource/Title/082610254

ORDER: https://www.amazon.com/Hospitals-Healthcare-Organizations-Management-Operational/dp/1439879907/ref=sr_1_4?s=books&ie=UTF8&qid=1334193619&sr=1-4

***

Share this:

  • Share on Tumblr
  • WhatsApp
  • More
  • Email
  • Print

Like this:

Like Loading...

Filed under: "Doctors Only", Drugs and Pharma, Experts Invited, Glossary Terms, Health Economics, Health Insurance | Tagged: drug prices, Drugs, Health Capital Consultants LLC, PBM, pharma, pharmacy, Pharmacy Benefits Managers, Will Americans Finally See Drug Prices Decrease? | Leave a comment »

CVS, Walgreens and Walmart: Opioid Settlement

Posted on November 3, 2022 by Dr. Marcinko

By Staff Reporters

***

***

CVS, Walgreens, and Walmart agree to pay $13 billion over opioids

The pharmacy chains have reached a tentative deal to settle thousands of lawsuits brought by state and local governments that accuse them of contributing to the opioid epidemic.

If the deal goes through, CVS and Walgreens will each cough up around $5 billion, and Walmart will reportedly be on the hook for $3 billion.

***

COMMENTS APPRECIATED

Thank You

***

ORDER: https://www.routledge.com/Risk-Management-Liability-Insurance-and-Asset-Protection-Strategies-for/Marcinko-Hetico/p/book/9781498725989

***

Share this:

  • Share on Tumblr
  • WhatsApp
  • More
  • Email
  • Print

Like this:

Like Loading...

Filed under: Breaking News, Drugs and Pharma, Ethics, Health Insurance, Risk Management | Tagged: CVs, Drugs, opioids, pharma, pharmaceuticals, Walgreen's, Walmart | Leave a comment »

Supreme Court Hears Oral Arguments on 340B Drug Pricing Cuts

Posted on January 19, 2022 by Dr. Marcinko

BY HEALTH CAPITAL CONSULTANTS, LLC

***

Supreme Court Hears Oral Arguments on 340B Cuts

On November 30, 2021, the U.S. Supreme Court heard oral arguments regarding the challenges arising from the cuts made by the Centers of Medicare & Medicaid Services (CMS) to the 340B Drug Pricing Program.

The 340B Drug Pricing Program allows hospitals and clinics that treat low-income, medically underserved patients to purchase certain “specified covered outpatient drugs” at discounted prices (applying a ceiling to what drug manufacturers may charge certain healthcare facilities) – 25% to 50% of what providers would typically pay – and then receive reimbursement pursuant to the rates set forth in the Outpatient Prospective Payment System (OPPS) at the same rate as all other providers. (Read more…)

***

HEALTH ECONOMICS CITE: https://www.r2library.com/Resource/Title/0826102549

PODCAST: https://medicalexecutivepost.com/2021/08/27/podcast-hospital-340-b-drug-programs/

***

***

***

***

Share this:

  • Share on Tumblr
  • WhatsApp
  • More
  • Email
  • Print

Like this:

Like Loading...

Filed under: Accounting, Breaking News, Drugs and Pharma, Experts Invited, Videos | Tagged: 340-B Drug Program, Centers of Medicare & Medicaid Services, CMS, CMS drug pricing program, Drugs, Health Capital Consultants LLC, Health Economics, OPPS, Outpatient Prospective Payment System, pharma, pharmacy | Leave a comment »

PODCAST: Prescription Patient Assistance Programs

Posted on January 11, 2022 by Dr. Marcinko

BY ERIC BRICKER MD

With 43 Million Americans Having Lost Their Job at Some Point During the Pandemic and About 1/2 Those Jobs Providing Health Insurance… the 1st Group–People Who Do Not Have Health Insurance–Needs to Be Aware of How These Programs Work.

In this Video You Will Learn the Patient Assistance Program Process for:

1) 2 of the Most Common Types of Insulin

2) The Highest-Revenue Medication in America: Humira

**Note: At the Time of the Video’s Recording, the Unemployment Rate in the US was 15%. As of November 2021, the Unemployment Rate is 4.2%.

***

***

COMMENTS APPRECIATED

Subscribe to the Medical Executive-Post

***

***

CITE: https://www.r2library.com/Resource/Title/082610254

***

Share this:

  • Share on Tumblr
  • WhatsApp
  • More
  • Email
  • Print

Like this:

Like Loading...

Filed under: Drugs and Pharma, Ethics, Experts Invited, Glossary Terms, Health Economics, Health Insurance, Healthcare Finance, iMBA, Inc., Videos | Tagged: Eric Bricker MD, Health Insurance, humira, insulin, Patient Assistance Programs, PBMs, pharma, pharmaceuticals, Prescription Patient Assistance Programs | 1 Comment »

PODCAST: The 10 Top Technology Trends Shaping the Future of the Pharma

Posted on October 8, 2021 by Dr. Marcinko

THE CULTURAL SHIFT

Dr. Bertalan Meskó, MD

The pharma industry has taken a big swung into digital transformation. All participants invest in digital health topics.

But as with all trending issues, and there is a lot of fuss that is hard to see through. As the medical community increasingly acknowledges the importance of digital health, the cultural shift we so often talk about is still a way to go. To change that, the first step is always getting to know what’s coming.

In this article, with podcast, Bert collected the trends changing the pharmaceutical industry.

ESSAY AND PODCAST: https://medicalfuturist.com/top-10-trends-shaping-future-pharma/?utm_source=The%20Medical%20Futurist%20Newsletter&utm_campaign=3a501b1978-EMAIL_CAMPAIGN_2021_09_05_Resend&utm_medium=email&utm_term=0_efd6a3cd08-3a501b1978-399696053&mc_cid=3a501b1978&mc_eid=40fee31c25#

YOUR THOUGHTS AND COMMENTS ARE APPRECIATED.

Thank You

***

****

Click to access foreword-mata.pdf

Share this:

  • Share on Tumblr
  • WhatsApp
  • More
  • Email
  • Print

Like this:

Like Loading...

Filed under: "Doctors Only", Drugs and Pharma, Experts Invited, Information Technology | Tagged: Dr. Bertalan Meskó, Drugs, medical digital transformation, pharma, pharma future, pharma trends | Leave a comment »

PODCASTS: FDA Pharmaceutical Industry Ties

Posted on September 15, 2021 by Dr. Marcinko

CONFLICTS OF INTEREST?

The New York Times Had an Excellent Article on the FDA on September 2, 2021.

The Article Described How the FDA Began Receiving Funding from the Pharmaceutical Industry Itself to Pay for FDA Employee Salaries in 1992–a Potential Conflict-of-Interest. Subsequently, a Study Found that 1/3 of Drugs Approved by the FDA Were Found to Have Safety Problems from 2000 -2010. Another Potential Conflict-of-Interest is Number of FDA Regulators Who Leave Their Positions to Take High-Paying Jobs at Pharmaceutical Companies.

By Eric Bricker MD

FDA rescinds emergency authorization for COVID-19 antibody treatment  bamlanivimab | TheHill

PODCAST:

***

YOUR COMMENTS ARE APPRECIATED.

Thank You

****

***

Share this:

  • Share on Tumblr
  • WhatsApp
  • More
  • Email
  • Print

Like this:

Like Loading...

Filed under: "Doctors Only", Drugs and Pharma, Ethics, Experts Invited, Op-Editorials, Videos | Tagged: Big Pharma, DEA, Drugs, Eric Bricker MD, FDA, NYT, pharma, pharma conflicts, pharmaceutical industry | Leave a comment »

The PBMI Innovation Challenge

Posted on August 6, 2021 by Dr. Marcinko

There’s still time!
Submit your innovative solution in patient health management to the Pharmacy Benefit Management Institute (PBMI) Innovation Challenge by August 6, 2021 for the chance to be among one of the 5 finalists selected to pitch their ideas before a panel of judges at the PBMI 2021 Annual Meeting!




Be sure to submit your idea by August 6, 2021 for the chance to be featured in an upcoming issue of Managed Healthcare Executive with a full-year integrated marketing program valued at over $100K, in addition to formal acknowledgment at this year’s PBMI Conference.

REGISTER: https://events.pbmi.com/event/31593a7e-d661-4ea5-abf2-5aa6473e1a14/summary

***

Share this:

  • Share on Tumblr
  • WhatsApp
  • More
  • Email
  • Print

Like this:

Like Loading...

Filed under: Drugs and Pharma | Tagged: Drugs, PBM, pharma, Pharmacy Benefit Mangers | 1 Comment »

Peri-Operative MEs and ADEs

Posted on December 14, 2015 by Dr. Marcinko

Join Our Mailing List

One in Twenty [1/20]

By http://www.MCOL.com

***

ImageProxy

***

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:

  • PRACTICES: www.BusinessofMedicalPractice.com
  • HOSPITALS: http://www.crcpress.com/product/isbn/9781466558731
  • CLINICS: http://www.crcpress.com/product/isbn/9781439879900
  • ADVISORS: www.CertifiedMedicalPlanner.org
  • FINANCE: Financial Planning for Physicians and Advisors
  • INSURANCE: Risk Management and Insurance Strategies for Physicians and Advisors
  • Dictionary of Health Economics and Finance
  • Dictionary of Health Information Technology and Security
  • Dictionary of Health Insurance and Managed Care

[HEALTH INSURANCE, MANAGED CARE, ECONOMICS, FINANCE AND HEALTH INFORMATION TECHNOLOGY COMPANION DICTIONARY SET]

Product DetailsProduct DetailsProduct Details

[Mike Stahl PhD MBA] *** [Foreword Dr.Mata MD CIS] *** [Dr. Getzen PhD]

***

Share this:

  • Share on Tumblr
  • WhatsApp
  • More
  • Email
  • Print

Like this:

Like Loading...

Filed under: Drugs and Pharma, Quality Initiatives | Tagged: ADEs, Drugs, MEs, pharma, www.MCOL.com | 1 Comment »

National Health Expenditure Growth

Posted on January 16, 2014 by Dr. Marcinko

Join Our Mailing List

A Report from the Office of the Actuary

Source: Centers for Medicare & Medicaid Services

According to the Centers for Medicare & Medicaid Services (CMS) Office of the Actuary, overall national health expenditures grew at an annual rate of 3.7 percent in 2012, marking the fourth consecutive year of low growth. Health spending as a share of gross domestic product fell slightly from 17.3 percent in 2011 to 17.2 percent in 2012.

Private Insurance

Private health insurance spending growth remained low. Private health insurance spending continued to grow at a low rate, increasing 3.2 percent in 2012 compared to 3.4 percent growth in 2011. Medicare spending growth continued to be low. Despite a large uptick in Medicare enrollment, Medicare spending growth slowed slightly in 2012, increasing by 4.8 percent compared to 5.0 percent growth in 2011.

The Totals for MC/MD

Total Medicare spending per enrollee grew by only 0.7 percent in 2012. Medicaid spending continued to grow at a historically low rate. Total Medicaid spending grew 3.3 percent in 2012. While an increase over 2011, this increase still represents historically low overall growth rates tied to improved economic conditions, as well as efforts by states to control costs.

Rx Drugs

Prescription drug spending growth was low. Retail prescription drug spending slowed in 2012, growing only 0.4 percent as the result of numerous drugs losing their patent protection, leading to increased sales of lower-cost generics. Nursing home spending growth slowed.

Pharma

Assessment

Spending for freestanding nursing care facilities and continuing care retirement communities increased by only 1.6 percent in 2012, down from 4.3 percent growth in 2011, due to a one-time Medicare rate adjustment for skilled nursing facilities.

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:

DICTIONARIES: http://www.springerpub.com/Search/marcinko
PHYSICIANS: www.MedicalBusinessAdvisors.com
PRACTICES: www.BusinessofMedicalPractice.com
HOSPITALS: http://www.crcpress.com/product/isbn/9781466558731
CLINICS: http://www.crcpress.com/product/isbn/9781439879900
BLOG: www.MedicalExecutivePost.com
FINANCE: Financial Planning for Physicians and Advisors
INSURANCE: Risk Management and Insurance Strategies for Physicians and Advisors

Product DetailsProduct Details

Product Details

Share this:

  • Share on Tumblr
  • WhatsApp
  • More
  • Email
  • Print

Like this:

Like Loading...

Filed under: Drugs and Pharma, Health Economics, Health Insurance | Tagged: Centers for Medicare & Medicaid Services, CMS, Drugs, National Health Expenditure Growth, pharma, Retail prescription drug spending | 1 Comment »

Doctors on Drugs

Posted on June 23, 2012 by Dr. Marcinko

Join Our Mailing List

Profitable Prescriptions?

Increasing in costs each year, prescription pills are one of the most profitable and dominating industries in the nation, with annual sales in the hundreds of billions. Prescribed medications constitute a significant bulk of work that medical coders must transcribe.

The Rx Pill Industry

Shockingly, the prescription pill industry uses questionable practices to increase their bottom line, and in turn, increase coding workload through unnecessary prescriptions. Though pharmaceutical companies have long-earned a reputation for wooing doctors with gifts, bribes, and incentives, it was only revealed in recent years that they’ve also been paying doctors huge sums of money to promote certain products. And, some and doctors are taking up on these offers.

These pre-selected medications are not only violating a conflict of interest, but they can also be largely responsible for increases in patient and insurance costs: a doctor may feel obligated to prescribe an expensive “sponsored” medication over a cheaper alternative.

Assessment

This in turn, is reflected on the overall rising cost of healthcare, which unfortunately, is exactly what the doctor ordered.

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

Our Other Print Books and Related Information Sources:

Health Dictionary Series: http://www.springerpub.com/Search/marcinko

Practice Management: http://www.springerpub.com/product/9780826105752

Physician Financial Planning: http://www.jbpub.com/catalog/0763745790

Medical Risk Management: http://www.jbpub.com/catalog/9780763733421

Hospitals: http://www.crcpress.com/product/isbn/9781439879900

Physician Advisors: www.CertifiedMedicalPlanner.org

Product DetailsProduct DetailsProduct Details

Share this:

  • Share on Tumblr
  • WhatsApp
  • More
  • Email
  • Print

Like this:

Like Loading...

Filed under: Drugs and Pharma, Ethics, Glossary Terms | Tagged: “sponsored” medication, Doctors on Drugs, pharma, pharmaceutical companies, prescription pills, Rx drugs | 7 Comments »

Doctors on Drugs?

Posted on December 7, 2011 by Dr. Marcinko

Sponsored Medications Increase MDs Bottom Line

Join Our Mailing List

Increasing in costs each year, prescription pills are one of the most profitable and dominating industries in the nation, with annual sales in the hundreds of billions. Prescribed medications constitute a significant bulk of work that medical coders must transcribe.

Shockingly, the prescription pill industry has questionable practices to increase their bottom line, and in turn, increase coding workload through unnecessary prescriptions.

Though pharmaceutical companies have long-earned a reputation for wooing doctors with gifts, bribes, and incentives, it was only revealed in recent years that they’ve also been paying doctors huge sums of money to promote certain products – and doctors are taking up these offers. These pre-selected medications are not only violating a conflict of interest, they can be largely responsible for increases in patient and insurance costs: a doctor may feel obligated to prescribe an expensive “sponsored” medication over a cheaper alternative.

This in turn, is reflected on the overall rising cost of healthcare, which unfortunately, is exactly what the doctor ordered.

Source: Medical Billing and Coding

Conclusion                

And so, your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

Our Other Print Books and Related Information Sources:

Health Dictionary Series: http://www.springerpub.com/Search/marcinko

Practice Management: http://www.springerpub.com/product/9780826105752

Physician Financial Planning: http://www.jbpub.com/catalog/0763745790

Medical Risk Management: http://www.jbpub.com/catalog/9780763733421

Healthcare Organizations: www.HealthcareFinancials.com

Physician Advisors: www.CertifiedMedicalPlanner.com

Subscribe Now: Did you like this Medical Executive-Post, or find it helpful, interesting and informative? Want to get the latest ME-Ps delivered to your email box each morning? Just subscribe using the link below. You can unsubscribe at any time. Security is assured.

Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos

Sponsors Welcomed: And, credible sponsors and like-minded advertisers are always welcomed.

Link: https://healthcarefinancials.wordpress.com/2007/11/11/advertise

Product Details

Share this:

  • Share on Tumblr
  • WhatsApp
  • More
  • Email
  • Print

Like this:

Like Loading...

Filed under: Drugs and Pharma, Ethics | Tagged: Drugs, pharma, pharmaceutical companies, prescription pills, sponsored drugs | 1 Comment »

Enter Margaret Hamburg

Posted on April 10, 2009 by Dr. Marcinko

The New FDA Nominee

By Staff Reporters

lombard-courtAccording to Tracy Staton and FiercePharma on April 7, Dr. Marcia Angell, former New England Journal of Medicine editor-in-chief and current Harvard Medical School lecturer, wrote a column in the Washington Post that set out a list of seven goals for Margaret Hamburg who awaits senate confirmation as FDA chief.

A New Book

Now, Angell has a particular point of view; she’s published a book called The Truth About the Drug Companies [How they Deceive us and What to Do About It]. Here they are, presented for your critique and consideration by the new FDA chief:

  • Repeal the Prescription Drug User Fee Act because it puts “the FDA on the payroll of the industry it regulates.”
  • Consultants for drug companies should be banned from advisory committees.
  • Enforce FDA mandates on post-marketing studies.
  • Review generics as quickly as it checks out branded meds.
  • Require drug-makers to compare their new drugs with similar existing meds.
  • Cease surrogate drug endpoints.
  • Bar DTC ads for three years after a new drug is approved.

Assessment

What has she missed? Are these guidelines fair or not? Will they be advocated by Hamburg, if confirmed?  

Conclusion

And so, your thoughts and comments on this Medical Executive-Post are appreciated? Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, be sure to subscribe to the ME-P. It is fast, free and secure.

Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com  or Bio: www.stpub.com/pubs/authors/MARCINKO.htm

Get our Widget: Get this widget!

Our Other Print Books and Related Information Sources:

Practice Management: http://www.springerpub.com/prod.aspx?prod_id=23759

Physician Financial Planning: http://www.jbpub.com/catalog/0763745790

Medical Risk Management: http://www.jbpub.com/catalog/9780763733421

Healthcare Organizations: www.HealthcareFinancials.com

Health Administration Terms: www.HealthDictionarySeries.com

Physician Advisors: www.CertifiedMedicalPlanner.com

Subscribe Now: Did you like this Medical Executive-Post, or find it helpful, interesting and informative? Want to get the latest ME-Ps delivered to your email box each morning? Just subscribe using the link below. You can unsubscribe at any time. Security is assured.

Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos

Share this:

  • Share on Tumblr
  • WhatsApp
  • More
  • Email
  • Print

Like this:

Like Loading...

Filed under: Alerts Sign-Up, Book Reviews, Breaking News, Drugs and Pharma, Ethics, Health Law & Policy | Tagged: big-pharma, drug, drug companies, DTC, FDA, generic drugs, Marcia Angell, Margaret Hamburg, NEJM, pharma, pharmaceuticals, trade drugs, Washington Post | 1 Comment »

  • Calendar

    • February 2023
      M T W T F S S
       12345
      6789101112
      13141516171819
      20212223242526
      2728  
      « Jan    
  • Advertising Info:

    • Advertise with Us!
    • Classified Ads
    • Dr. David E. Marcinko MBA
    • ME-P MAST HEAD
    • Support Med Executive-Post
  • Book Offerings:

    • Business of Medical Practice [Transformational Health 2.0 Skills for Doctors]
    • Comprehensive Financial Planning Strategies for Doctors and Advisors [Best Practices from Leading Certified Medical Planners™]
    • Financial Management Strategies for Hospitals [Tools, Techniques, Checklists and Case Studies]
    • Financial Planning Handbook For Physicians and Advisors
    • Hospitals & Healthcare Organizations [Management Strategies, Operational Techniques, Tools, Templates, and Case Studies]
    • Insurance and Risk Management Strategies for Physicians and Advisors
    • Risk Management, Liability Insurance, and Asset Protection Strategies for Doctor and Advisors [Best Practices from Leading Consultants and Certified Medical Planners™]
  • Dictionary Offerings:

    • Dictionary of Health Economics and Finance
    • Dictionary of Health Information Technology and Security
    • Dictionary of Health Insurance and Managed Care
  • Dr. David Marcinko [Publication List]

    • Google Scholar Search
    • National Institute of Health – Part I
    • National Institute of Health – Part II
  • Education Online:

    • CERTIFIED MEDICAL PLANNER® Program for Financial Advisors and Consultants
  • Health Dictionary Series Wiki Project

    • e-Health Dictionary Series®
  • Lower Extremity Medicine & Surgery

    • e-Podiatry Consent Forms®
    • Podiatry Board Exams and State Licensure Preparation
  • Pending NIHCM Grant Applications:

    • "Exposing Hobson's Choice and Rationing in Medicine"
  • Practice Lists:

    • eMRs, HIT and Security [Checklists & Case Models]
    • Medical Office Checklists [Checklists & Case Models]
    • Practice Case Examples [Checklists & Case Models]
  • Professor Marcinko

    • Comprehensive [CV] Website
    • Curriculum Development
    • Virtual Internet Chatting
  • Related Blogs:

    • Alert and Oriented
    • Association of Private Enterprise Education
    • Ayn Rand Institute
    • Benjamin Rush Institute
    • Data Breaches
    • e-Financial Consultants
    • European Center of Austrian Economics Foundation
    • FLIP IT Consulting
    • Foundation for Economic Education
    • Free Market Medical Association
    • Health Capital Consultants
    • Health Care Renewal
    • Health Economics
    • Healthcare Town Hall
    • International Health Economics Association
    • Library of Economics and Liberty
    • Ludwig von Mises Institute
    • Society for the Development of Austrian Economics
    • Taking Hayek Seriously
    • The Austrian Economics Center
    • Top 100 Economics Blogs
    • Uneasy Money
    • www.fi360.com
  • Speaker's Bureau:

    • Dr. David E. Marcinko MBA CMP™ [Publisher-in-Chief]
  • Thought-Leaders:

    • Ahmad Hashem; MD, PhD
    • Andrew Schwartz CPA
    • Anju D. Jessani; MBA APM®
    • Anthony Silva; MD MBA
    • Brian J. Knabe; MD CFP® CMP™
    • Carol S. Miller BSN MBA CMP™ [Hon]
    • Darrell K. Pruitt; DDS
    • David B. Nash; MD, MBA
    • David K. Luke MIM CMP™
    • Edwin Morrow; CFP® RFC
    • Edwin P. Morrow III; J.D., LL.M., MBA, CFP®, RFC®
    • Eric A. Dover MD
    • Frank A. Cappiello; PhD MBA
    • Gary L. Bode DPM CPA MSA CMP™ [Hon]
    • Ike Devji; JD
    • J. Christopher Miller JD
    • J. Wesley Boyd MD PhD
    • James Winston Phillips MD JD LLM MBA
    • Kernan T. Manion MD
    • Lloyd M. Krieger; MD, MBA
    • Michael J. Stahl; PhD MBA
    • Michael Lawrence Langan MD
    • Neil H. Baum MD MBA
    • Perry D'Alessio CPA
    • Richard A. Berning; MD
    • Rick Kahler MSFS CFP®
    • Rick Mata; MD, MS, CMP™
    • Shahid N. Shah; MS
    • Somnath Basu; PhD, MBA
    • Susan L. Theuns; PA-C, CPC, CHC, MA
    • Thomas A. Muldowney MSFS CFP AIF CMP™
    • Thomas E. Getzen; PhD
    • Timothy McIntosh MBA MPH CFP® CMP™ [Hon]
    • Vitaliy N. Katsenelson CFA
  • White Papers:

    • Competitive Modeling and Analysis in Healthcare

Blog at WordPress.com. WP Designer.

  • Follow Following
    • The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants
    • Join 1,247 other followers
    • Already have a WordPress.com account? Log in now.
    • The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants
    • Customize
    • Follow Following
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...
 

    %d bloggers like this: